| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(01)00232-X |
| P698 | PubMed publication ID | 11804666 |
| P50 | author | Katarína Sebekova | Q60490959 |
| August Heidland | Q100698720 | ||
| P2093 | author name string | Reinhard Schinzel | |
| Viera Kupcová | |||
| P2860 | cites work | Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells | Q24530074 |
| Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins | Q28645665 | ||
| Relevance of oxidative and carbonyl stress to long-term uremic complications. | Q33998575 | ||
| Transection of the oesophagus for bleeding oesophageal varices | Q34211834 | ||
| Advanced protein glycosylation in diabetes and aging | Q34298835 | ||
| Advanced glycosylation: chemistry, biology, and implications for diabetes and aging | Q34351918 | ||
| Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells | Q34380394 | ||
| Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake | Q34381796 | ||
| Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications | Q35661794 | ||
| Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. | Q37308593 | ||
| Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. | Q37363088 | ||
| Letter: Endotoxaemia in liver cirrhosis: treatment with polymyxin B | Q39324451 | ||
| Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products | Q41043761 | ||
| Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class A. | Q42158174 | ||
| Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products | Q43560094 | ||
| N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function | Q43750780 | ||
| Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis. | Q51734844 | ||
| Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity | Q73883776 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver cirrhosis | Q147778 |
| liver transplantation | Q1368191 | ||
| P304 | page(s) | 66-71 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation | |
| P478 | volume | 36 |
| Q37326771 | AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis. |
| Q36578536 | Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice |
| Q36915810 | Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food. |
| Q41206326 | Advanced glycation end product (AGE)-induced hepatic stellate cell activation via autophagy contributes to hepatitis C-related fibrosis |
| Q38193463 | Advanced glycation end products and diabetic retinopathy |
| Q51373390 | Advanced glycation end products in myocardial reperfusion injury. |
| Q37357141 | Bio-ecological control of chronic liver disease and encephalopathy. |
| Q35576075 | Chemical modification of proteins by lipids in diabetes |
| Q26781477 | Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma |
| Q34409300 | Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling |
| Q26781156 | Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management |
| Q90720617 | Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products |
| Q38773241 | Diabetes mellitus in patients with cirrhosis: clinical implications and management |
| Q37072018 | Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent? |
| Q44401494 | Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products. |
| Q38258947 | Galectin-3: an emerging all-out player in metabolic disorders and their complications |
| Q41134548 | Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease |
| Q33811776 | Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease. |
| Q39036315 | Hepatogenous diabetes: Is it time to separate it from type 2 diabetes? |
| Q64925211 | Hot water extracts of pressure-roasted dried radish attenuates hepatic oxidative stress via Nrf2 up-regulation in mice fed high-fat diet. |
| Q36852110 | Impact of glucose levels on advanced glycation end products in hemodialysis |
| Q46639089 | Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N(epsilon)-(carboxymethyl) lysine |
| Q40872573 | Increased Circulating Advanced Oxidation Protein Products and High-Sensitive Troponin T in Cirrhotic Patients with Chronic Hepatitis C: A Preliminary Report |
| Q46613224 | Increased protein glycation in cirrhosis and therapeutic strategies to prevent it. |
| Q92662145 | Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity |
| Q26745839 | Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation |
| Q87011119 | Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells |
| Q42747339 | Oxidative damage in the liver of rats treated with glycolaldehyde |
| Q43109146 | Oxidative stress-associated rise of hepatic protein glycation increases inflammatory liver injury in uncoupling protein-2 deficient mice |
| Q35583145 | Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation |
| Q39332869 | Pentoxifylline alleviates high-fat diet-induced non-alcoholic steatohepatitis and early atherosclerosis in rats by inhibiting AGE and RAGE expression |
| Q36916192 | Reactive metabolites and AGE-RAGE-mediated inflammation in patients following liver transplantation |
| Q37300540 | Senescence-dependent impact of anti-RAGE antibody on endotoxemic liver failure |
| Q42250966 | Serum autofluorescence, a potential serum marker for the diagnosis of liver fibrosis in rats |
| Q36816945 | Soluble receptor for advanced glycation end products and risk of liver cancer |
| Q43187791 | Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats |
| Q47095662 | The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC). |
| Q77530330 | The liver is the main site for metabolism of circulating advanced glycation end products |
| Q26797382 | The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis |
| Q51487967 | Toxicological evaluation of advanced glycation end product Nε-(carboxymethyl)lysine: Acute and subacute oral toxicity studies. |
| Q46495572 | Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients |
| Q80483015 | Unchanged serum levels of advanced glycation endproducts in patients with liver disease |
| Q37857797 | What is the role of the receptor for advanced glycation end products-ligand axis in liver injury? |
Search more.